Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Alnylam Pharmaceuticals Inc. (ALNY)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1. 700,000 $88,935 10.75%
2.
Casdin Capital

Eli Casdin

200,000 $25,410 6.18%
3.
Blue Ridge Capital

John Griffin

1,338,300 $170,031 -13% 5.65%
4.
Perceptive Advisors

Joseph Edelman

1,330,802 $169,079 -26% 5.6%
5.
Slate Path Capital

David Greenspan

447,000 $56,791 -21% 5.58%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$71.87 297,501 Large Shareholder 10,554,134 2017-05-31 Filing
$65.35 11,500 Officer 11,500 2017-05-30 Filing
$37.00 27,900 Director 27,900 2016-10-13 Filing
$58.36 2,000 Director 4,000 2016-03-09 Filing
$69.75 205,030 Large Shareholder 10,256,633 2016-02-01 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$141.47 100 Officer 0 2018-03-26 Filing
$137.78 419 Officer 100 2018-03-26 Filing
$137.09 2,394 Officer 519 2018-03-26 Filing
$136.00 4,308 Officer 2,913 2018-03-26 Filing
$152.79 300 Officer 14,500 2018-03-20 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 83,967 $10,000 1.23%
2. 100,913 $12,019 0.05%
3. 18,002 $2,144 0.03%
4. 2,000 $238 0.02%
5. 8,030 $956 0.01%
News See All